MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinoma.

[1]  Ling Zhou,et al.  Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth , 2016, Cell Death & Disease.

[2]  Z. Tan,et al.  MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3ζ/STAT3/HIF-1α/VEGF signaling , 2016, Oncotarget.

[3]  Y. Shentu,et al.  Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. , 2016, The New England journal of medicine.

[4]  Gong Yang,et al.  MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells , 2016, Oncotarget.

[5]  Jian Wang,et al.  MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway , 2016, Oncotarget.

[6]  U. Pastorino,et al.  Conversion to stem‐cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells , 2015, Molecular oncology.

[7]  Minoru Kanehisa,et al.  KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..

[8]  Chuanhe Yang,et al.  The Role of miR‐21 in Cancer , 2015, Drug development research.

[9]  Zhidong Liu,et al.  Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation , 2015, Oncotarget.

[10]  Li‐jun Wu,et al.  Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis. , 2015, Molecular bioSystems.

[11]  E. Izaurralde,et al.  Towards a molecular understanding of microRNA-mediated gene silencing , 2015, Nature Reviews Genetics.

[12]  A. Moiyadi,et al.  MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells , 2015, Journal of Molecular Neuroscience.

[13]  N. Seki,et al.  Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma. , 2015, International journal of oncology.

[14]  Lu‐Hai Wang,et al.  Regulation of cancer metastasis by microRNAs , 2015, Journal of Biomedical Science.

[15]  I. Keklikoglou,et al.  MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes , 2014, Oncogene.

[16]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[17]  J. Ahn,et al.  CIP4 Promotes Lung Adenocarcinoma Metastasis and Is Associated with Poor Prognosis , 2014, Oncogene.

[18]  D. Kemp,et al.  Selective repression of the oncogene cyclin D1 by the tumor suppressor miR-206 in cancers , 2014, Oncogenesis.

[19]  Wei Zhu,et al.  MicroRNA‐206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D , 2014, Pigment cell & melanoma research.

[20]  Thomas Tuschl,et al.  Mammalian miRNA curation through next-generation sequencing , 2013, Front. Genet..

[21]  E. D. Bal de Kier Joffé,et al.  TGF-beta specifically enhances the metastatic attributes of murine lung adenocarcinoma: implications for human non-small cell lung cancer , 2013, Clinical & Experimental Metastasis.

[22]  Kwok-Kin Wong,et al.  Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. , 2013, The Journal of clinical investigation.

[23]  S. Tavazoie,et al.  Control of metastatic progression by microRNA regulatory networks , 2013, Nature Cell Biology.

[24]  Xiaolong Yang,et al.  Fer Protein-Tyrosine Kinase Promotes Lung Adenocarcinoma Cell Invasion and Tumor Metastasis , 2013, Molecular Cancer Research.

[25]  J. Lebrun.  The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis , 2012, ISRN molecular biology.

[26]  Nahum Sonenberg,et al.  The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC , 2012, Nature Structural &Molecular Biology.

[27]  N. Seki,et al.  microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers , 2012, Oncotarget.

[28]  N. Matsuura,et al.  Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer. , 2011, The Annals of thoracic surgery.

[29]  Ming Liu,et al.  Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. , 2011, Anticancer research.

[30]  S. Luo,et al.  RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries. , 2011, RNA.

[31]  P. Kantharidis,et al.  TGF-β Regulates miR-206 and miR-29 to Control Myogenic Differentiation through Regulation of HDAC4 , 2011, The Journal of Biological Chemistry.

[32]  Rafael Sirera,et al.  The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[33]  E. Brambilla,et al.  The evolving role of histology in the management of advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  F. Ramirez,et al.  Fibrillin assemblies: extracellular determinants of tissue formation and fibrosis , 2010, Fibrogenesis & tissue repair.

[35]  Gary D. Bader,et al.  The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..

[36]  O. Delattre,et al.  MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas , 2010, British Journal of Cancer.

[37]  H. V. Jagadish,et al.  ConceptGen: a gene set enrichment and gene set relation mapping tool , 2010, Bioinform..

[38]  A. Hata,et al.  Control of microRNA biogenesis by TGFbeta signaling pathway-A novel role of Smads in the nucleus. , 2009, Cytokine & growth factor reviews.

[39]  J. Qu,et al.  MicroRNA-1/206 Targets c-Met and Inhibits Rhabdomyosarcoma Development* , 2009, The Journal of Biological Chemistry.

[40]  M. Ladanyi,et al.  The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. , 2009, The Journal of clinical investigation.

[41]  M. Tamura,et al.  Bone morphogenetic protein-2 down-regulates miR-206 expression by blocking its maturation process. , 2009, Biochemical and biophysical research communications.

[42]  George A. Calin,et al.  MicroRNAs — the micro steering wheel of tumour metastases , 2009, Nature Reviews Cancer.

[43]  J. McCarthy.  MicroRNA-206: the skeletal muscle-specific myomiR. , 2008, Biochimica et biophysica acta.

[44]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[45]  Aamir Ahmad,et al.  Evolving role of uPA/uPAR system in human cancers. , 2008, Cancer treatment reviews.

[46]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[47]  P. Dijke,et al.  Extracellular control of TGFβ signalling in vascular development and disease , 2007, Nature Reviews Molecular Cell Biology.

[48]  K. Mohammad,et al.  Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. , 2007, Cancer research.

[49]  J. Mesirov,et al.  GenePattern 2.0 , 2006, Nature Genetics.

[50]  K. M. Mulder,et al.  Requirement of TGF‐β receptor‐dependent activation of c‐Jun N‐terminal kinases (JNKs)/stress‐activated protein kinases (Sapks) for TGF‐β up‐regulation of the urokinase‐type plasminogen activator receptor , 2004, Journal of cellular physiology.

[51]  H. Kato,et al.  Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues. , 2003, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[52]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[53]  Justin P. Annes,et al.  Making sense of latent TGFβ activation , 2003, Journal of Cell Science.

[54]  H. Wada,et al.  Clinical significance of nm23 expression in resected pathologic-stage I, non-small cell lung cancer. , 2002, The Annals of thoracic surgery.

[55]  T. Tsushima,et al.  Transforming growth factor‐β1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma , 2001 .

[56]  J. Murphy-Ullrich,et al.  Activation of latent TGF-β by thrombospondin-1: mechanisms and physiology , 2000 .

[57]  J. Rueff,et al.  MicroRNAs and Cancer Drug Resistance. , 2016, Methods in molecular biology.